Dimensional Fund Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,481,405
| Closed | -$55.8M | – | 3518 |
|
|
2021
Q1 | $55.8M | Sell |
1,481,405
-62,375
| -4% | -$1.56M | 0.02% | 1353 |
|
|
2020
Q4 | $26.3M | Sell |
1,543,780
-38,790
| -2% | -$486K | 0.01% | 1834 |
|
|
2020
Q3 | $7.44M | Sell |
1,582,570
-88,245
| -5% | -$448K | ﹤0.01% | 2330 |
|
|
2020
Q2 | $10.2M | Sell |
1,670,815
-132,403
| -7% | -$545K | ﹤0.01% | 2196 |
|
|
2020
Q1 | $4.09M | Buy |
1,803,218
+103,863
| +6% | +$441K | ﹤0.01% | 2486 |
|
|
2019
Q4 | $7.8M | Sell |
1,699,355
-26,697
| -2% | -$106K | ﹤0.01% | 2445 |
|
|
2019
Q3 | $6.69M | Sell |
1,726,052
-16,054
| -0.9% | -$88.1K | ﹤0.01% | 2498 |
|
|
2019
Q2 | $10.5M | Buy |
1,742,106
+83,400
| +5% | +$797K | ﹤0.01% | 2379 |
|
|
2019
Q1 | $22.2M | Buy |
1,658,706
+174,528
| +12% | +$1.99M | 0.01% | 1990 |
|
|
2018
Q4 | $13.8M | Buy |
1,484,178
+71,001
| +5% | +$845K | 0.01% | 2188 |
|
|
2018
Q3 | $19.7M | Buy |
1,413,177
+223,523
| +19% | +$3.32M | 0.01% | 2126 |
|
|
2018
Q2 | $18.8M | Buy |
1,189,654
+147,904
| +14% | +$2.58M | 0.01% | 2133 |
|
|
2018
Q1 | $17.9M | Buy |
1,041,750
+67,474
| +7% | +$1.32M | 0.01% | 2122 |
|
|
2017
Q4 | $21.4M | Buy |
974,276
+102,779
| +12% | +$3.31M | 0.01% | 2038 |
|
|
2017
Q3 | $35.7M | Sell |
871,497
-18,079
| -2% | -$568K | 0.02% | 1636 |
|
|
2017
Q2 | $26.8M | Sell |
889,576
-43,834
| -5% | -$1.37M | 0.01% | 1830 |
|
|
2017
Q1 | $33.7M | Buy |
933,410
+92,338
| +11% | +$4.07M | 0.02% | 1586 |
|
|
2016
Q4 | $42.1M | Buy |
841,072
+93,211
| +12% | +$4.9M | 0.02% | 1318 |
|
|
2016
Q3 | $39.3M | Buy |
747,861
+276,325
| +59% | +$13.2M | 0.02% | 1300 |
|
|
2016
Q2 | $19.5M | Buy |
+471,536
| New | +$20.5M | 0.01% | 1865 |
|
Dimensional Fund Advisors's FPRX Position: Q2 2021 in Review
Dimensional Fund Advisors sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 1,481,405 shares — an estimated $55.8M sold.
Dimensional Fund Advisors first reported a position in FPRX in Q2 2016 and held it in 20 quarters. The position peaked at $55.8M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Dimensional Fund Advisors reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Dimensional Fund Advisors sold 1,481,405 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $55.8M.
- Dimensional Fund Advisors first reported a position in Five Prime Therapeutics, Inc. in Q2 2016 and held it in 20 quarters.
- Dimensional Fund Advisors's Five Prime Therapeutics, Inc. position peaked at $55.8M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Dimensional Fund Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.